Bone Marrow Transplantation News

ASH announced this year’s recipients of its honorific awards.

Allogeneic hematopoietic stem cell transplants with total body irradiation and etoposide vs. chemotherapy-based conditioning regimens conferred superior OS for children with acute lymphoblastic leukemia, randomized study results showed.

Nearly one-fifth of patients who undergo hematopoietic stem cell transplantation develop symptoms of PTSD within 6 months, according to study results presented during the ASCO20 Virtual Scientific Program.

Autologous hematopoietic stem cell transplant conferred survival outcomes comparable to chimeric antigen receptor T-cell therapy for certain patients with lymphoma, according to results presented during the ASCO20 Virtual Scientific Program.

The National Comprehensive Cancer Network and NCCN Foundation announced five recipients of the 10th annual NCCN Foundation Young Investigator Awards.

The FDA has granted fast track designation to liposomal cyclosporine A for inhalation for treatment of bronchiolitis obliterans syndrome, according to a press release.

Ruxolitinib appeared to be more effective than common treatments for patients with glucocorticoid-refractory acute graft-versus-host-disease, according to results of a randomized phase 3 study published in The New England Journal of Medicine.

Memorial Sloan Kettering Cancer Center announced several appointments.

ASH Research Collaborative’s Data Hub launched an international data registry to help inform care for individuals with blood cancers and COVID-19.

The FDA granted priority review to the allogeneic cell therapy remestemcel-L for the treatment of children with steroid-refractory acute graft-versus-host disease, according to the agent’s manufacturer.